TC-tuned Biocompatible suspension of La0.73Sr0.27MnO3 for magnetic hyperthermia

被引:71
作者
Prasad, N. K. [1 ]
Rathinasamy, K. [2 ]
Panda, D. [2 ]
Bahadur, D. [1 ]
机构
[1] Indian Inst Technol, Dept Met Engn & Mat Sci, Bombay 400076, Maharashtra, India
[2] Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India
关键词
biocompatibility/soft tissue; in vitro; nanomaterials/nanophase; tissue culture; microtubulles;
D O I
10.1002/jbm.b.30959
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
La1-xSrxMnO3, a ferromagnet with high magnetization and Curie temperature T-C below 70 degrees C, enables its use for magnetic hyperthermia treatment of cancer with a possibility of in vivo temperature control. We found that La0.73Sr0.27MnO3 particles of size range 20-100 nm showed saturation magnetization around 38 emu/g at 20 kOe and a T-C value of 45 degrees C. Aqueous suspension of these nanoparticles was prepared using a polymer, acrypol 934, and the biocompatibility of the suspension was examined using HeLa cells. A good heating ability of the magnetic suspension was obtained in the presence of AC magnetic field, and it was found to increase with the amplitude of field. The suspension having concentration of 0.66 mg/mL (e.g., 0.66 mg of nanoparticles with acropyl per milliliter of culture media) was observed to be biocompatible even after 96 h of treatment, as estimated by sulforhodamine B and trypan blue dye exclusion assays. Further, the treatment with the aforementioned concentration did not alter the microtubule cytoskeleton or the nucleus of the cells. However, the hare particles (concentration of 0.66 mg of nanoparticles per milliliter of culture media, but without acropyl) decreased the viability of cell significantly. Our in vitro studies suggest that the suspension (concentration of 0.66 mg/mL) may further be analyzed for in vivo studies. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 30 条
[1]  
Brezovich I.A., 1988, MED PHYSICS MONOGRAP, V16, P82
[2]   Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro [J].
Brusentsov, NA ;
Gogosov, VV ;
Brusentsova, TN ;
Sergeev, AV ;
Jurchenko, NY ;
Kuznetsov, AA ;
Kuznetsov, OA ;
Shumakov, LI .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2001, 225 (1-2) :113-117
[3]  
CHEN G, 1988, CANCER CHEMOTH PHARM, V22, P303
[4]  
CULLITY BD, 1972, INTRO MAGNETIC MAT, P410
[5]   Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration [J].
Erikson, KM ;
Syversen, T ;
Aschner, JL ;
Aschner, M .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2005, 19 (03) :415-421
[6]   A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis [J].
Finn, WF ;
Joy, MS .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (05) :657-664
[7]   Preparation and characterization of La1-xSrxMnO3+δ (0≤x≤0.6) powder by sol-gel processing [J].
Gaudon, M ;
Laberty-Robert, C ;
Ansart, F ;
Stevens, P ;
Rousset, A .
SOLID STATE SCIENCES, 2002, 4 (01) :125-133
[8]   Synthesis of capped nanosized Mn1-xZnxFe2O4 (0 ≤ x≤ 0.8) by microwave refluxing for bio-medical applications [J].
Giri, J ;
Sriharsha, T ;
Asthana, S ;
Rao, TKG ;
Nigam, AK ;
Bahadur, D .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2005, 293 (01) :55-61
[9]   Preparation and investigation of potentiality of different soft ferrites for hyperthermia applications [J].
Giri, Y ;
Pradhan, P ;
Sriharsha, T ;
Bahadur, D .
JOURNAL OF APPLIED PHYSICS, 2005, 97 (10)
[10]   INTRACELLULAR HYPERTHERMIA - BIOPHYSICAL APPROACH TO CANCER-TREATMENT VIA INTRACELLULAR TEMPERATURE AND BIOPHYSICAL ALTERATIONS [J].
GORDON, RT ;
HINES, JR ;
GORDON, D .
MEDICAL HYPOTHESES, 1979, 5 (01) :83-102